Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Goddard, Maria
and
Drummond, Michael
1991.
The economic evaluation of cancer treatments and programmes.
European Journal of Cancer and Clinical Oncology,
Vol. 27,
Issue. 10,
p.
1191.
Drummond, Michael F.
1992.
Basing Prescription Drug Payment on Economic Analysis: The Case of Australia.
Health Affairs,
Vol. 11,
Issue. 4,
p.
191.
Drummond, Michael
1992.
Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?.
Health Economics,
Vol. 1,
Issue. 2,
p.
85.
Robinson, R
1993.
Economic evaluation and health care. What does it mean?.
BMJ,
Vol. 307,
Issue. 6905,
p.
670.
Drummond, Michael
and
O'Brienm, Bernie
1993.
Clinical importance, statistical significance and the assessment of economic and quality‐of‐life outcomes.
Health Economics,
Vol. 2,
Issue. 3,
p.
205.
Drummond, Michael
Torrance, George
and
Mason, James
1993.
Cost-effectiveness league tables: More harm than good?.
Social Science & Medicine,
Vol. 37,
Issue. 1,
p.
33.
Sculpher, Mark J.
Bryan, Stirling
Dwyer, Nuala
Hutton, John
and
Stirrat, Gordon M.
1993.
An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia.
BJOG: An International Journal of Obstetrics & Gynaecology,
Vol. 100,
Issue. 3,
p.
244.
Strauss, M.J.
Bleecker, G.C.
and
Steinwald, A.B.
1993.
Cost-effectiveness analyses in a changing health care environment: New issues and challenges.
European Journal of Cancer,
Vol. 29,
Issue. ,
p.
S3.
Bonsel, G.J.
Rutten, F.F.H.
and
Uyl-de Groot, C.A.
1993.
Economic evaluation alongside cancer trials: Methodological and practical aspects.
European Journal of Cancer,
Vol. 29,
Issue. ,
p.
S10.
Morris, Jenny
and
Goddard, Maria
1993.
Economic evaluation and quality of life assessments in cancer clinical trials: The CHART trial.
European Journal of Cancer,
Vol. 29,
Issue. 5,
p.
766.
HILLNER, BRUCE E.
SMITH, THOMAS J.
and
DESCH, CHRISTOPHER E.
1993.
Principles of Cost Effectiveness Analysis for the Assessment of Current and New Therapies.
Journal of Hematotherapy,
Vol. 2,
Issue. 4,
p.
501.
McGhan, William F.
Bootman, J. Lyle
Townsend, Raymond J.
Sacristán, José A.
Soto, Javier
and
Galende, Ines
1993.
Evaluation of Pharmacoeconomic Studies: Utilization of a Checklist.
Annals of Pharmacotherapy,
Vol. 27,
Issue. 9,
p.
1126.
Drummond, M.
and
Backhouse, M.
1993.
Assessing the economic benefits of antiherpes therapy.
Journal of Medical Virology,
Vol. 41,
Issue. S1,
p.
51.
Mason, J
Drummond, M
and
Torrance, G
1993.
Some guidelines on the use of cost effectiveness league tables..
BMJ,
Vol. 306,
Issue. 6877,
p.
570.
Harris, Anthony H.
1994.
Economic Appraisal in the Regulation of Pharmaceuticals in Australia: Its Rationale and Potential Impact.
Australian Economic Review,
Vol. 27,
Issue. 2,
p.
99.
Bennett, Charles L.
Armitage, Jack L.
Buchner, Deborah
and
Gulati, Subhash
1994.
Economic Analysis in Phase III Clinical Cancer Trials.
Cancer Investigation,
Vol. 12,
Issue. 3,
p.
336.
Rutten‐van Mölken, Maureen P. M. H.
Van, Eddy K. A.
and
van Vliet, René C. J. A.
1994.
Statistical analysis of cost outcomes in a randomized controlled clinical trial.
Health Economics,
Vol. 3,
Issue. 5,
p.
333.
Briggs, Andrew
Sculpher, Mark
and
Buxton, Martin
1994.
Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis.
Health Economics,
Vol. 3,
Issue. 2,
p.
95.
Leidl, Reiner M.
1994.
Some Factors to Consider when Using the Results of Economic Evaluation Studies at the Population Level.
International Journal of Technology Assessment in Health Care,
Vol. 10,
Issue. 3,
p.
467.
Davies, Linda
Coyle, Douglas
and
Drummond, Michael
1994.
Current status of economic appraisal of health technology in the European community: Report of the network.
Social Science & Medicine,
Vol. 38,
Issue. 12,
p.
1601.